Pfizer stock popped Monday on a report activist investor Starboard Value took a roughly $1 billion stake in the struggling drugmaker. Please watch the video at Investors.com - How To Buy Stocks ...

Activist investor Starboard Value has launched a broadside against Pfizer's leadership under chief executive Albert Bourla, claiming at least $20 billion in value – and possibly as much as $60 ...

Bourla’s attempting to counter the blistering critique from Starboard’s CEO Jeff Smith, who has taken Pfizer’s management to ...

Two former Pfizer executives drawn into a campaign by activist investor Starboard Value to shake up the company have withdrawn their support for the plan. Pfizer's ex-chair and chief executive Ian ...

Pfizer’s buyout of Seagen was among the issues Starboard Value pointed to in October of last year when it called on the company’s board to “hold management accountable” for what it ...

Starboard’s Kenvue saga came shortly after it picked up a $1 billion stake in Pfizer and initiated a proxy fight with the New York-based drugmaker. However, after criticizing the company’s R&D ...

Starboard Value CEO says Pfizer's board should hold management accountable Activist hedge fund Starboard Value's chief executive officer said on Tuesday that drugmaker Pfizer's board needs to hold ...

Pfizer offers a substantial 6.7% dividend yield and has increased its dividend for 16 consecutive years. The stock trades at a forward P/E of just 8.7, close to historical lows. Despite policy ...

The American hedge fund Starboard Value has acquired a stake in Pfizer Inc. worth $1 billion. This is reported in the Starboard Value press release. Starboard Value is committed to accelerating the ...

Despite facing legal challenges and investor pressure, such as litigation related to Oxbryta and interactions with activist investor Starboard, Pfizer has remained resilient. Its strategic ...